Orchid Pharma Board Approves ₹600 Crore Fundraise for Strategic Growth
Orchid Pharma Ltd's board has approved an enabling resolution to raise up to ₹600 crore through equity or debt, representing 11.2% of its current market cap.
Tuesday, 20 October 2026
NSE & BSE filings, as they land
ALFA News
Straight from the exchange filing